Obesity and cardiovascular events in patients with established coronary disease

European Heart Journal

Volumn 27, Issue 12, 2006, Pages 1416-1422

  Domanski, Michael J ^a   Jablonski, Kathleen A ^b   Rice, Madeline Murguia ^b   Fowler, Sarah E ^b   Braunwald, Eugene ^c  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Coronary artery disease; Obesity; Sex

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; PLACEBO; POTASSIUM SPARING DIURETIC AGENT; SEX HORMONE; TRANDOLAPRIL;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEATH; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; OUTCOME ASSESSMENT; POST HOC ANALYSIS; PREVALENCE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SEX DIFFERENCE; STROKE;

BODY MASS INDEX; COHORT STUDIES; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY DISEASE; CORONARY DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY; RANDOMIZED CONTROLLED TRIALS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; SEX FACTORS;

EID: 33745697920     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehl022     Document Type: Article

References (25)

1. Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 2002;288:1723-1727.
2. Freedman DS, Khan LK, Serdula MK, Galuska DA, Dietz WH. Trends and correlates of class 3 obesity in the United States from 1990 through 2000. JAMA 2002;288:1758-1761.
3. Eckel RH, Barouch WW, Ershow AG. Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on the pathophysiology of obesity-associated cardiovascular disease. Circulation 2002;105:2923-2928.
4. Krauss RM, Winston M, Fletcher RN, Grundy SM. Obesity: impact on cardiovascular disease. Circulation 1998;98:1472-1476.
5. Visscher TL, Seidell JC. The public health impact of obesity. Annu Rev Publ Health 2001;22:355-375.
6. Dagenais GR, Yi Q, Mann JF, Bosch J, Pogue J, Yusuf S, on behalf of the Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Prognostic impact of body weight and abdominal obesity in women and men with cardiovascular disease. Am Heart J 2005;149:54-60.
7. Kaplan RC, Heckbert SR, Furberg CD, Psaty BM. Predictors of subsequent coronary events, stroke, and death among survivors of first hospitalized myocardial infarction. J Clin Epidemiol 2002;55:654-664.
8. Pryor DB, Bruce RA, Chaitman BR, Fisher L, Gajewski J, Hammermeister KE, Pauker SG, Stokes J III. Task Force I: Determination of prognosis in patients with ischaemic heart disease. J Am Coll Cardiol 1989;14:1016-1025.
9. Rea TD, Heckbert SR, Kaplan RC, Psaty BM, Smith NL, Lemaitre RN, Lin D. Body mass index and the risk of recurrent coronary events following acute myocardial infarction. Am J Cardiol 2001;88:467-472.
10. Kragelund C, Hassager C, Hildebrandt P, Torp-Pedersen C, Kober L, TRACE study group. Impact of obesity on long-term prognosis following acute myocardial infarction. Int J Cardiol 2005;98:123-131.
11. Widlansky ME, Sesso HD, Rexrode KM, Manson JE, Gaziano JM. Body mass index and total and cardiovascular mortality in men with a history of cardiovascular disease. Arch Intern Med 2004;164:2326-2332.
12. Pfeffer MA, Domanski M, Rosenberg Y, Verter J, Geller N, Albert P, Hsia J, Braunwald E. Prevention of events with angiotensin-converting enzyme inhibition (the PEACE study design). Am J Cardiol 1998;82:25H-30H.
13. Braunwald E, Domanski MJ, Fowler SE, Geller NL, Gersh BJ, Hsia J, Pfeffer MA, Rice MM, Rosenberg YD, Rouleau JL, PEACE Trial Investigators. Angiotensin-converting-enzyme inhibition in stable coronary artery disease. N Engl J Med 2004;351:2058-2068.
14. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. The Evidence Report. NIH Publication No. 98-4083, September 1998, The National Institutes of Health.
15. Berg C, Rosengren A, Aires N, Lappas G, Toren K, Thelle D, Lissner L. Trends in overweight and obesity from 1985 to 2002 in Goteborg, West Sweden. Int J Obes (Lond) 2005;29:916-924.
16. Iwao N, Iwao S, Muller DC, Koda M, Ando F, Shimokata H, Kobayashi F, Andres R. Differences in the relationship between lipid CHD risk factors and body composition in Caucasians and Japanese. Int J Obes (Lond) 2005;29:228-235.
17. Rogowski O, Shapira I, Toker S, Melamed S, Shirom A, Berliner S, Zeltser D. Obesity-related correlation between C-reactive protein and the calculated 10-y Framingham Coronary Heart Disease Risk Score. Int J Obes (Lond) 2005;29:772-777.
18. Belsley DA, Kuh E, Welsch RE. Regression Diagnostics. New York, NY: John Wiley & Sons Inc.; 1980.
19. Wolk R, Berger P, Lennon RJ, Brilakis ES, Somers VK. Body mass index: a risk factor for unstable angina and myocardial infarction in patients with angiographically confirmed coronary artery disease. Circulation 2003;108:2206-2211.
20. Haffner S, Taegtmeyer H. Epidemic obesity and the metabolic syndrome. Circulation 2003;108:1541-1545.
21. Ginsberg HN. Insulin resistance and cardiovascular disease. J Clin Invest 2000;106:453-458.
22. Lee RT, Libby P. The unstable atheroma. Arterioscler Thromb Vasc Biol 1997;17:1859-1867.
23. Rioufol G, Finet G, Ginon I, Andre-Fouet X, Rossi R, Vialle E, Desjoyaux E, Convert G, Huret JF, Tabib A. Multiple atherosclerotic plaque rupture in acute coronary syndrome: a three-vessel intravascular ultrasound study. Circulation 2002;106:804-808.
24. Lane JT, Mack-Shipman LR, Anderson JC, Moore TE, Erickson JM, Ford TC, Stoner JA, Larsen JL. Comparison of CT and dual-energy DEXA using a modified trunk compartment in the measurement of abdominal fat. Endocrine 2005;27:295-300.
25. Rexrode KM, Carey VJ, Hennekens CH, Walters EE, Colditz GA, Stampfer MJ, Willett WC, Manson JE. Abdominal adiposity and coronary heart disease in women. JAMA 1998;280:1843-1848.